Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
milnacipran (savella) (1 trial)
Dyssomnias (Phase 4)
Fibromyalgia (Phase 4)
Myofascial Pain Syndromes (Phase 4)
Parasomnias (Phase 4)
Sleep Wake Disorders (Phase 4)
Trials (1 total)
Trial APIs (1 total)